Sjogren syndrome

References

Key articles

Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013 Sep;9(9):544-56. Abstract

Fox RI. Sjogren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31. Abstract

Haugen AJ, Peen E, Hulten B, et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordland Health Study. Scand J Rheumatol. 2008 Jan-Feb;37(1):30-4. Abstract

Harris VM, Sharma R, Cavett J, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome. Clin Immunol. 2016 Jul;168:25-29.Full text  Abstract

Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren's syndrome. Nat Clin Pract Rheumatol. 2006 May;2(5):252-61. Abstract

Venables PJ. Sjogren's syndrome. Best Pract Res Clin Rheumatol. 2004 Jun;18(3):313-29. Abstract

Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8.Full text  Abstract

Whitcher JP, Shiboski CH, Shiboski SC, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry. Am J Ophthalmol. 2010 Mar;149(3):405-15. Abstract

Hernández-Molina G, Avila-Casado C, Nuñez-Alvarez C, et al. Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjogren's syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology (Oxford). 2015 Mar;54(3):441-8. Abstract

Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014 Feb 18;160(4):233-42. Abstract

Reference articles

1. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013 Sep;9(9):544-56. Abstract

2. Fox PC. Autoimmune diseases and Sjogren's syndrome, an autoimmune exocrinopathy. Ann N Y Acad Sci. 2007 Mar;1098:15-21. Abstract

3. Anaya JM, Tobon GJ, Vega P, et al. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J Rheumatol. 2006 Nov;33(11):2227-34. Abstract

4. Steinberg AD, Talal N. The coexistence of Sjogren's syndrome and systemic lupus erythematosus. Ann Intern Med. 1971 Jan;74(1):55-61. Abstract

5. Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979 May;66(5):733-6. Abstract

6. Foster H, Fay A, Kelly C, et al. Thyroid disease and other autoimmune phenomena in a family study of primary Sjogren's syndrome. Br J Rheumatol. 1993 Jan;32(1):36-40. Abstract

7. Alarcon-Segovia D, Ibanez G, Hernandez-Ortiz J, et al. Sjogren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med. 1974 Jul;57(1):78-85. Abstract

8. Manthorpe R, Manthorpe T. Primary Sjogren's syndrome - epidemiology and prognosis. Akt Rheumatol. 2005;30:27-31.

9. Fox RI. Sjogren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31. Abstract

10. Kabasakal Y, Kitapciglu G, Turk T, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006 Sep-Oct;35(5):379-83. Abstract

11. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004 Jun 28;164(12):1275-84.Full text  Abstract

12. Haugen AJ, Peen E, Hulten B, et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordland Health Study. Scand J Rheumatol. 2008 Jan-Feb;37(1):30-4. Abstract

13. Schein OD, Hochberg MC, Muñoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999 Jun 28;159(12):1359-63.Full text  Abstract

14. Scofield RH, Kurien BT, Reichlin M. Immunologically restricted and inhibitory anti-Ro in monozygotic twins. Lupus. 1997;6(4):395-8. Abstract

15. Bolstad AI, Haga HJ, Wassmuth R, et al. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol. 2000 Sep;27(9):2264-6. Abstract

16. Nordmark G, Alm GV, Ronnblom L. Mechanisms of disease: primary Sjogren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol. 2006 May;2(5):262-9. Abstract

17. Gottenberg JE, Busson M, Loiseau P, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 2003 Aug;48(8):2240-5. Abstract

18. Scofield RH. Genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol. 2009 Sep;21(5):448-53. Abstract

19. Nagata Y, Inoue H, Yamada K, et al. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients. Immunology. 2004 Feb;111(2):223-9.Full text  Abstract

20. Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren's syndrome. Transl Res. 2006 Dec;148(6):281-8. Abstract

21. Scheinfeld N. Sjogren syndrome and systemic lupus erythematosus are distinct conditions. Dermatol Online J. 2006 Jan 27;12(1):4.Full text  Abstract

22. Hammi AR, Al-Hashimi IH, Nunn ME, et al. Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren's syndrome. J Oral Pathol Med. 2005 Apr;34(4):198-203. Abstract

23. Miller AV, Ranatunga SK, Francis ML, et al. Sjogren syndrome. August 2016. [internet publication].Full text

24. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjogren's syndrome. Am J Ophthalmol. 2005 Nov;140(5):898-9. Abstract

25. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001 Sep;2(9):777-80. Abstract

26. Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol. 2006 Mar;142(3):371-6. Abstract

27. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient? J Rheumatol. 2003 Nov;30(11):2413-9. Abstract

28. Delaleu N, Jonsson R, Koller MM. Sjogren's syndrome. Eur J Oral Sci. 2005 Apr;113(2):101-13. Abstract

29. Liu K, Kurien BT, Zimmerman SL, et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheumatol. 2016 May;68(5):1290-1300.Full text  Abstract

30. Harris VM, Sharma R, Cavett J, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome. Clin Immunol. 2016 Jul;168:25-29.Full text  Abstract

31. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren's syndrome. Nat Clin Pract Rheumatol. 2006 May;2(5):252-61. Abstract

32. Cimaz R, Casadei A, Rose C, et al. Primary Sjogren’s syndrome paediatric age: a multicentre survey. Eur J Pediatr. 2003 Oct;162(10):661-5. Abstract

33. Sumida T, Azuma N, Moriyama M, et al. Clinical practice guideline for Sjögren's syndrome 2017. Mod Rheumatol. 2018 May;28(3):383-408. Abstract

34. Romão VC, Talarico R, Scirè CA, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(suppl 1):e000789.Full text  Abstract

35. Venables PJ. Sjogren's syndrome. Best Pract Res Clin Rheumatol. 2004 Jun;18(3):313-29. Abstract

36. Fox PC, Brennan M, Pillemer S, et al. Sjogren's syndrome: a model for dental care in the 21st century. J Am Dent Assoc. 1998 Jun;129(6):719-28. Abstract

37. Shiboski SC, Shiboski CH, Criswell L, et al; Sjogren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjogren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87.Full text  Abstract

38. Scofield AK, Radfar L, Ice JA, et al. Relation of sensory peripheral neuropathy in Sjogren syndrome to anti-Ro/SSA. J Clin Rheumatol. 2012 Sep;18(6):290-3. Abstract

39. Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):798-802. Abstract

40. Agmon-Levin N, Kivity S, Tzioufas AG, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. J Autoimmun. 2012 Sep;39(3):234-9. Abstract

41. Napeñas JJ, Rouleau TS. Oral complications of Sjogren's syndrome. Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):55-62. Abstract

42. Al-Hashimi I, Khuder S, Haghighat N, et al. Frequency and predictive value of the clinical manifestations in Sjogren's syndrome. J Oral Pathol Med. 2001 Jan;30(1):1-6. Abstract

43. Soto-Rojas AE, Kraus A. The oral side of Sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res. 2002 Mar-Apr;33(2):95-106. Abstract

44. Klasser GD, Balasubramaniam R, Epstein J. Topical review-connective tissue diseases: orofacial manifestations including pain. J Orofac Pain. 2007 Summer;21(3):171-84. Abstract

45. Liao MT, Chien WC, Wang JC, et al. Increased risk of bisphosphonate-related osteonecrosis of the jaw in patients with Sjögren's syndrome: nationwide population-based cohort study. BMJ Open. 2019 Feb 13;9(2):e024655.Full text  Abstract

46. Seneff S, Swanson NL, Koenig G, et al. Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins. Dis Markers. 2016 Sep 28;2016:8376979.Full text  Abstract

47. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of venous thromboembolism in patients with Sjögren's syndrome: a systematic review and meta-analysis. Clin Exp Rheumatol. 2015 Sep-Oct;33(5):746-50. Abstract

48. Aviña-Zubieta JA, Jansz M, Sayre EC, et al. The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study. J Rheumatol. 2017 Aug;44(8):1184-1189.Full text  Abstract

49. Chung WS, Lin CL, Sung FC, et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study. J Rheumatol. 2014 May;41(5):909-15. Abstract

50. Tsai YD, Chien WC, Tsai SH, et al. Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan. BMJ Open. 2018 Sep 21;8(9):e022326.Full text  Abstract

51. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-8.Full text  Abstract

52. Colella G, Cannavale R, Vicidomini A, et al. Salivary gland biopsy: a comprehensive review of techniques and related complications. Rheumatology (Oxford). 2010 Nov;49(11):2117-21. Abstract

53. Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren’s syndrome - a place in the diagnostic criteria? Rheum Dis Clin North Am. 2016 Aug;42(3):501-17. Abstract

54. Zhang X, Zhang S, He J, et al. Ultrasonographic evaluation of major salivary glands in primary Sjogren's syndrome: comparison of two scoring systems. Rheumatology (Oxford). 2015 Sep;54(9):1680-7.Full text  Abstract

55. Luciano N, Baldini C, Tarantini G, et al. Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjogren's syndrome from undifferentiated connective tissue diseases. Rheumatology (Oxford). 2015 Dec;54(12):2198-204. Abstract

56. Takagi Y, Sumi M, Nakamura H, et al. Ultrasonography as an additional item in the American College of Rheumatology classification of Sjogren's syndrome. Rheumatology (Oxford). 2014 Nov;53(11):1977-83.Full text  Abstract

57. Barendregt PJ, Visser MR, Smets EM, et al. Fatigue in primary Sjogren's syndrome. Ann Rheum Dis. 1998 May;57(5):291-5.Full text  Abstract

58. Gudbjornsson B, Broman JE, Hetta J, et al. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol. 1993 Dec;32(12):1072-6. Abstract

59. Strombeck B, Ekdahl C, Manthorpe R, et al. Physical capacity in women with primary Sjogren's syndrome: a controlled study. Arthritis Rheum. 2003 Oct 15;49(5):681-8. Abstract

60. Newbrun E. Current treatment modalities of oral problems of patients with Sjogren's syndrome: caries prevention. Adv Dent Res. 1996 Apr;10(1):29-34. Abstract

61. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren's syndrome. BMC Clin Pathol. 2005 Mar 1;5(1):4.Full text  Abstract

62. Tucci M, Quatraro C, Silvestris F. Sjogren's syndrome: an autoimmune disorder with otolaryngological involvement. Acta Otorhinolaryngol Ital. 2005 Jun;25(3):139-44.Full text  Abstract

63. Segerberg-Konttinen M, Konttinen YT, Bergroth V. Focus score in the diagnosis of Sjogren's syndrome. Scand J Rheumatol Suppl. 1986;61:47-51. Abstract

64. Whitcher JP, Shiboski CH, Shiboski SC, et al; Sjogren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren's Syndrome International Registry. Am J Ophthalmol. 2010 Mar;149(3):405-15. Abstract

65. Daniels TE, Benn DK. Is sialography effective in diagnosing the salivary component of Sjogren's syndrome? Adv Dent Res. 1996 Apr;10(1):25-8. Abstract

66. Nicholson DA. Contrast media in sialography: a comparison of Lipiodol Ultra Fluid and Urografin 290. Clin Radiol 1990 Dec;42(6):423-6. Abstract

67. Hernández-Molina G, Avila-Casado C, Nuñez-Alvarez C, et al. Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjogren's syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology (Oxford). 2015 Mar;54(3):441-8. Abstract

68. Shiboski S, Shiboski C; EULAR Sjogren’s Syndrome Classification Criteria Working Group. Proposed ACR-EULAR classification criteria for Sjogren’s syndrome: development and validation. Abstract S1.1. 13th International Symposium on Sjogren’s Syndrome, May 2015; Bergen, Norway. [internet publication].Full text

69. Shiboski CH. New ACR-EULAR Sjogren’s syndrome classification criteria and updates. Abstract. American College of Rheumatology National Meeting, September 2015; San Francisco, CA.

70. Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjogren syndrome: a systematic review. JAMA. 2010 Jul 28;304(4):452-60.Full text  Abstract

71. Kalk WW, Mansour K, Vissink A, et al. Oral and ocular manifestations in Sjogren's syndrome. J Rheumatol. 2002 May;29(5):924-30. Abstract

72. Samarkos M, Moutsopoulos HM. Recent advances in the management of ocular complications of Sjogren's syndrome. Curr Allergy Asthma Rep. 2005 Jul;5(4):327-32. Abstract

73. Jacobi C, Cursiefen C. Ophthalmological complications in Sjogren's syndrome [in German]. Z Rheumatol. 2010 Feb;69(1):32-40. Abstract

74. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Punctal occlusion in Sjogren's syndrome needs clarification. Nat Rev Rheumatol. 2012;8:752. Abstract

75. Zandbelt MM, van den Hoogen FH, de Wilde PC, et al. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjogren's syndrome. Ann Rheum Dis. 2001 May;60(5):511-3. Abstract

76. Mavragani CP, Moutsopoulos HM. Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol. 2007 Jun;32(3):284-91. Abstract

77. Mavragani CP, Moutsopoulos HM. Immunosuppression and immunomodulation in Sjogren’s syndrome - what is the evidence? Does it relieve the sicca symptoms? Aktuelle Rheumatologie. 2005;30:66-70.

78. Fox PC, Datiles M, Atkinson JC, et al. Prednisone and piroxicam for treatment of primary Sjogren’s syndrome. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):149-56. Abstract

79. Akpek EK, Lindsley KB, Adyanthaya RS, et al. Treatment of Sjogren's syndrome-associated dry eye: an evidence-based review. Ophthalmology. 2011 Jul;118(7):1242-52. Abstract

80. Gündüz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren’s syndrome. Acta Ophthalmol (Copenh). 1994 Aug;72(4):438-42. Abstract

81. Fan WS, Hung HL, Liao HP, et al. Topical cyclosporine therapy for keratoconjunctivitis sicca in Sjogren’s syndrome. Tzu Chi Med J. 2003;15:85-89.

82. Drosos AA, Skopouli FN, Galanopoulu VK, et al. Cyclosporin A therapy in patients with primary Sjogren's syndrome: results at one year. Scand J Rheumatol Suppl. 1986;61:246-9. Abstract

83. Drosos AA, Skopouli FN, Costopoulos JS, et al. Cyclosporin A (CyA) in primary Sjogren’s syndrome: a double blind study. Ann Rheum Dis. 1986 Sep;45(9):732-5.Full text  Abstract

84. Skopouli FN, Jagiello P, Tsifetaki N, et al. Methotrexate in primary Sjogren's syndrome. Clin Exp Rheumatol. 1996 Sep-Oct;14(5):555-8. Abstract

85. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome. Br J Rheumatol. 1995 Apr;34(4):326-33. Abstract

86. Thanou-Stavraki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum. 2008 Apr;37(5):273-92. Abstract

87. Touma Z, Sayad J, Arayssi T. Successful treatment of Sjogren's syndrome with rituximab. Scand J Rheumatol. 2006 Jul-Aug;35(4):323-5. Abstract

88. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014 Feb 18;160(4):233-42. Abstract

89. Gottenberg JE, Ravaud P, Puéchal X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA. 2014 Jul 16;312(3):249-58.Full text  Abstract

90. Manoussakis MN, Moutsopoulos HM. Anti-malarials in Sjogren's syndrome - the Greek experience. Lupus. 1996;5(suppl 1):28S-30S. Abstract

91. Scofield RH. Vasculitis in Sjogren's Syndrome. Curr Rheumatol Rep. 2011 Dec;13(6):482-8. Abstract

92. Doyle MK. Vasculitis associated with connective tissue disorders. Curr Rheumatol Rep. 2006 Aug;8(4):312-6. Abstract

93. Wakasugi D, Kato T, Gono T, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod Rheumatol. 2009;19(4):437-40. Abstract

94. Rist S, Sellam J, Hachulla E, et al. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjogren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken). 2011 Sep;63(9):1339-44. Abstract

95. Morozumi S, Kawagashira Y, Iijima M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci. 2009 Apr 15;279(1-2):57-61. Abstract

96. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jan;97(1):28-46. Abstract

97. O'Neill ID, Scully C. Biologics in oral medicine: Sjogren syndrome. Oral Dis. 2013 Mar;19(2):121-7. Abstract

98. Izumi M, Eguchi K, Nakamura H, et al. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjogren's syndrome. Ann Rheum Dis. 1998 Aug;57(8):464-9.Full text  Abstract

99. Aragona P, Spinella R, Rania L, et al. Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome. Eur J Ophthalmol. 2013 May-Jun;23(3):368-76. Abstract

100. Pan Q, Angelina A, Marrone M, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2017;(2):CD009327.Full text  Abstract

101. López-García JS, García-Lozano I, Rivas L, et al. Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study. Acta Ophthalmol. 2014 Feb;92(1):e22-9.Full text  Abstract

102. Ba J, Wu Y, Li Y, et al. Updated meta-analysis of acupuncture for treating dry eye. Med Acupuncture. 2013;25:317-327.

103. Vivino FB, Al-Hashimi I, Khan Z, et al; P92-01 Study Group. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med. 1999 Jan 25;159(2):174-81.Full text  Abstract

104. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol. 2007 Jun;32(3):265-74. Abstract

105. Fox RI. Sjogren's syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs. 2000 Sep;9(9):2007-16. Abstract

106. Mariette X. Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis. 2001 Nov;60(11):1007-10.Full text  Abstract

107. Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging. 2009 Nov;24(4):299-309. Abstract

Use of this content is subject to our disclaimer